MINNEAPOLIS--(BUSINESS WIRE)--According to research published in the Nov. 9, 2006, issue of The New England Journal of Medicine, deep brain stimulation – a therapy pioneered by Medtronic, Inc. (NYSE:MDT) – can provide significant and sustainable benefits to people with disabling forms of dystonia, a neurological movement disorder that forces parts of the body into abnormal, sometimes painful, movements or postures.
